Science

Abbott Labs to Pay $1.5 Billion to Resolve Criminal & Civil Investigations of Off-label Promotion of Depakote

Company Maintained Specialized Sales Force to Market Drug for Off Label Purposes; Targeted Elderly Dementia Patients in Nursing Homes Washington, DC—(ENEWSPF)—May 7, 2012.  Global Health Care Company Abbott Laboratories Inc. has pleaded guilty and agreed to pay $1.5 billion to resolve its criminal and civil liability arising from the company’s[Read More…]

Awake Mental Replay of Past Experiences Critical for Learning

Blocking it stumps memory-guided decision-making in rats — NIH-funded study Bethesda, Maryland–(ENEWSPF)–May 7, 2012.  Awake mental replay of past experiences is essential for making informed choices, suggests a study in rats. Without it, the animals’ memory-based decision-making faltered, say scientists funded by the National Institutes of Health. The researchers blocked[Read More…]

Countries Agree to Extend Negotiations on Rio+20 Outcome Document

NEW YORK–(ENEWSPF)–5 May 2012.  Representatives from governments negotiating the outcome document for the United Nations Sustainable Development Conference (Rio+20) today agreed to add five more days of deliberations to bridge differences that have kept them from making further progress in negotiations. “The present negotiation approach has run its course,” said[Read More…]

Target: Drug-resistant Bacteria

Engineers design nanoparticles that deliver high doses of antibiotics directly to bacteria. CAMBRIDGE, Mass.–(ENEWSPF)–May 3, 2012.  Over the past several decades, scientists have faced challenges in developing new antibiotics even as bacteria have become increasingly resistant to existing drugs. One strategy that might combat such resistance would be to overwhelm[Read More…]

Most read stories this week

Take a Survey

ARCHIVES